These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1312085)

  • 61. Molecular Mechanism for PACAP 38-Induced Neurite Outgrowth in PC12 Cells.
    Shibato J; Takenoya F; Hirabayashi T; Kimura A; Yamashita M; Takasaki I; Rakwal R; Shioda S
    Neural Plast; 2021; 2021():2522454. PubMed ID: 34422037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats.
    Läuffer JM; Modlin IM; Hinoue T; Kidd M; Zhang T; Schmid SW; Tang LH
    Gastroenterology; 1999 Mar; 116(3):623-35. PubMed ID: 10029621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants.
    Dautzenberg FM; Mevenkamp G; Wille S; Hauger RL
    J Neuroendocrinol; 1999 Dec; 11(12):941-9. PubMed ID: 10583729
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
    Delgado M; De la Fuente M; Martínez C; Gomariz RP
    J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adrenal pheochromocytoma PC12h cells respond to pituitary adenylate cyclase activating polypeptide.
    Watanabe T; Ohtaki T; Kitada C; Tsuda M; Fujino M
    Biochem Biophys Res Commun; 1990 Nov; 173(1):252-8. PubMed ID: 2175177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of pituitary adenylate cyclase activating polypeptide on vasopressin-induced proliferation of aortic smooth muscle cells: comparison with vasoactive intestinal polypeptide.
    Oiso Y; Kotoyori J; Murase T; Ito Y; Kozawa O
    Biochem Cell Biol; 1993; 71(3-4):156-61. PubMed ID: 7691092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro.
    Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD
    Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs.
    Naruse S; Suzuki T; Ozaki T
    Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility.
    Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M
    Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
    Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 67 kDa protein mediates pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated insulin secretion in a hamster clonal beta-cell line.
    Kulkarni RN; Smith DM; Ghatei MA; Bloom SR
    J Endocrinol; 1995 Oct; 147(1):121-30. PubMed ID: 7490525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity.
    Foda HD; Sharaf HH; Absood A; Said SI
    Peptides; 1995; 16(6):1057-61. PubMed ID: 8532588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).
    Miyata A; Jiang L; Dahl RD; Kitada C; Kubo K; Fujino M; Minamino N; Arimura A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):643-8. PubMed ID: 2383262
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: molecular identification and interaction with vasoactive intestinal peptide (VIP).
    Tatsuno I; Gottschall PE; Arimura A
    Peptides; 1991; 12(3):617-21. PubMed ID: 1923939
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
    Naruse S; Suzuki T; Ozaki T; Nokihara K
    Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.